Pacific Biosciences Of California Gross Margin 2010-2024 | PACB

Current and historical gross margin for Pacific Biosciences Of California (PACB) over the last 10 years. The current gross profit margin for Pacific Biosciences Of California as of December 31, 2024 is %.
Pacific Biosciences Of California Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2024-12-31 $0.15B $0.04B 24.03%
2024-09-30 $0.17B $0.04B 21.39%
2024-06-30 $0.19B $0.05B 23.81%
2024-03-31 $0.20B $0.06B 27.36%
2023-12-31 $0.20B $0.05B 26.87%
2023-09-30 $0.17B $0.05B 28.82%
2023-06-30 $0.15B $0.05B 30.82%
2023-03-31 $0.13B $0.05B 33.83%
2022-12-31 $0.13B $0.05B 38.58%
2022-09-30 $0.14B $0.06B 44.85%
2022-06-30 $0.14B $0.06B 44.60%
2022-03-31 $0.14B $0.06B 44.44%
2021-12-31 $0.13B $0.06B 45.04%
2021-09-30 $0.12B $0.05B 43.44%
2021-06-30 $0.11B $0.05B 42.45%
2021-03-31 $0.09B $0.04B 41.30%
2020-12-31 $0.08B $0.03B 40.51%
2020-09-30 $0.08B $0.03B 42.50%
2020-06-30 $0.08B $0.03B 40.96%
2020-03-31 $0.09B $0.04B 40.66%
2019-12-31 $0.09B $0.04B 38.46%
2019-09-30 $0.08B $0.03B 33.73%
2019-06-30 $0.08B $0.02B 30.38%
2019-03-31 $0.08B $0.02B 30.26%
2018-12-31 $0.08B $0.03B 31.65%
2018-09-30 $0.08B $0.03B 33.33%
2018-06-30 $0.09B $0.03B 36.67%
2018-03-31 $0.09B $0.03B 36.36%
2017-12-31 $0.09B $0.03B 36.17%
2017-09-30 $0.10B $0.04B 37.89%
2017-06-30 $0.10B $0.04B 42.71%
2017-03-31 $0.10B $0.04B 45.36%
2016-12-31 $0.09B $0.05B 49.45%
2016-09-30 $0.10B $0.06B 59.41%
2016-06-30 $0.09B $0.05B 60.00%
2016-03-31 $0.09B $0.06B 61.70%
2015-12-31 $0.09B $0.05B 58.06%
2015-09-30 $0.07B $0.03B 43.24%
2015-06-30 $0.08B $0.04B 46.91%
2015-03-31 $0.07B $0.03B 38.81%
2014-12-31 $0.06B $0.02B 37.70%
2014-09-30 $0.05B $0.02B 41.51%
2014-06-30 $0.04B $0.01B 25.64%
2014-03-31 $0.03B $0.01B 23.53%
2013-12-31 $0.03B $0.01B 21.43%
2013-09-30 $0.03B $0.00B 16.00%
2013-06-30 $0.02B $0.00B 14.29%
2013-03-31 $0.02B $0.00B 9.09%
2012-12-31 $0.03B $0.00B 3.85%
2012-09-30 $0.03B $0.00B 6.25%
2012-06-30 $0.04B $0.01B 12.50%
2012-03-31 $0.04B $0.01B 29.55%
2011-12-31 $0.03B $0.01B 38.24%
2011-09-30 $0.02B $0.01B 50.00%
2011-06-30 $0.01B $0.01B 72.73%
2011-03-31 $0.00B $0.00B 100.00%
2010-12-31 $0.00B $0.00B 100.00%
Sector Industry Market Cap Revenue
Medical MED INSTRUMENTS $0.339B $0.154B
Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved.
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) US $189.754B 83.11
Thermo Fisher Scientific (TMO) US $159.887B 19.34
Alcon (ALC) CH $48.486B 32.23
Edwards Lifesciences (EW) US $44.472B 29.10
IDEXX Laboratories (IDXX) US $38.242B 43.61
DexCom (DXCM) US $32.004B 49.47
IQVIA Holdings (IQV) US $27.061B 14.97
Mettler-Toledo (MTD) US $22.925B 27.19
STERIS (STE) IE $22.088B 25.26
Waters (WAT) US $20.850B 29.52
SONOVA HOLDING (SONVY) CH $18.568B 0.00
Hologic (HOLX) US $12.153B 13.11
Sysmex ADR (SSMXY) JP $11.545B 0.00
Penumbra (PEN) US $11.463B 89.97
Globus Medical (GMED) US $9.891B 22.90
Masimo (MASI) US $8.993B 37.74
Teleflex (TFX) US $5.861B 9.22
Glaukos (GKOS) US $5.001B 0.00
Integer Holdings (ITGR) US $4.385B 22.97
PROCEPT BioRobotics (PRCT) US $3.077B 0.00
TransMedics (TMDX) US $3.043B 89.09
Veracyte (VCYT) US $2.377B 42.75
Nihon Kohden (NHNKY) JP $2.113B 11.55
LivaNova (LIVN) GB $2.005B 12.14
Elekta AB (EKTAY) SE $1.960B 17.62
Alphatec Holdings (ATEC) US $1.753B 0.00
Tandem Diabetes Care (TNDM) US $1.431B 0.00
Integra LifeSciences Holdings (IART) US $1.302B 6.58
Pulse Biosciences (PLSE) US $1.156B 0.00
Artivion (AORT) US $0.996B 93.32
OPKO Health (OPK) US $0.930B 0.00
AxoGen (AXGN) US $0.780B 0.00
IRadimed (IRMD) US $0.680B 35.65
Mesa Laboratories (MLAB) US $0.647B 14.14
RxSight (RXST) US $0.644B 0.00
SiBone (SIBN) US $0.595B 0.00
AVANOS MEDICAL, INC (AVNS) US $0.565B 9.10
ORTHOFIX MEDICAL INC (OFIX) US $0.538B 0.00
OrthoPediatrics (KIDS) US $0.520B 0.00
Beta Bionics (BBNX) US $0.513B 0.00
Treace Medical Concepts (TMCI) US $0.457B 0.00
Delcath Systems (DCTH) US $0.415B 0.00
ClearPoint Neuro (CLPT) US $0.404B 0.00
NeuroPace (NPCE) US $0.392B 0.00
AngioDynamics (ANGO) US $0.377B 0.00
Semler Scientific (SMLR) US $0.347B 7.36
Tactile Systems Technology (TCMD) US $0.333B 17.82
Neuronetics (STIM) US $0.301B 0.00
CVRx (CVRX) US $0.207B 0.00
908 Devices (MASS) US $0.200B 0.00
Inogen (INGN) US $0.194B 0.00
Alpha Tau Medical (DRTS) IL $0.183B 0.00
LENSAR (LNSR) US $0.165B 0.00
Spectral Diagnostics (EDTXF) CA $0.163B 0.00
Anteris Technologies Global (AVR) AU $0.160B 0.00
Sight Sciences (SGHT) US $0.158B 0.00
Accuray (ARAY) US $0.140B 0.00
Lucid Diagnostics (LUCD) US $0.135B 0.00
KORU Medical Systems (KRMD) US $0.132B 0.00
Atossa Genetics (ATOS) US $0.110B 0.00
Rapid Micro Biosystems (RPID) US $0.102B 0.00
Monogram Orthopaedics (MGRM) US $0.102B 0.00
Microbot Medical (MBOT) US $0.083B 0.00
InspireMD (NSPR) IL $0.083B 0.00
EDAP TMS S.A (EDAP) FR $0.082B 0.00
Sensus Healthcare (SRTS) US $0.071B 10.82
EnVVeno Medical (NVNO) US $0.062B 0.00
Hyperfine (HYPR) US $0.054B 0.00
Zomedica (ZOMDF) US $0.052B 0.00
Positron (POSC) US $0.050B 0.00
Vicarious Surgical (RBOT) US $0.049B 0.00
Baird Medical Investment Holdings (BDMD) $0.036B 0.00
Biosig Technologies (BSGM) US $0.033B 0.00
Precision Optics (POCI) US $0.032B 0.00
Spectral AI (MDAI) US $0.032B 0.00
DarioHealth (DRIO) US $0.031B 0.00
Envoy Medical (COCH) US $0.029B 0.00
NexGel (NXGL) US $0.020B 0.00
Adagio Medical Holdings (ADGM) US $0.019B 0.00
Ekso Bionics Holdings (EKSO) US $0.014B 0.00
PAVmed (PAVM) US $0.014B 0.00
Accelerate Diagnostics (AXDX) US $0.013B 0.00
Inspira Technologies OXY B.H.N (IINN) IL $0.008B 0.00
Tenon Medical (TNON) US $0.007B 0.00
SINTX TECHNOLOGIES, INC (SINT) US $0.007B 0.00
WORK Medical Technology Group (WOK) CN $0.007B 0.00
Autonomix Medical (AMIX) US $0.005B 0.00
ReShape Lifesciences (RSLS) US $0.005B 0.00
Nuwellis (NUWE) US $0.005B 0.00
Check-Cap (CHEK) IL $0.004B 0.00
Nanovibronix (NAOV) US $0.004B 0.00
Venus Concept (VERO) CA $0.004B 0.00
ENDRA Life Sciences (NDRA) US $0.003B 0.00
Helius Medical Technologies (HSDT) US $0.002B 0.00
Avinger (AVGR) US $0.002B 0.00
Bluejay Diagnostics (BJDX) US $0.001B 0.00
Spinal Elements Holdings (SPEL) US $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) DE $0.000B 15.32
Longview Acquisition II (LGV) US $0.000B 0.00